Skip to main content
. 2019 Dec 27;11(12):752–760. doi: 10.4254/wjh.v11.i12.752

Table 4.

Management and outcomes, n (%)

GCH on native liver, n = 40 GCH on allograft, n = 10
Management
Immunosuppression 11 (28) 4 (40)
Supportive care 10 (25) 0 (0)
Liver transplantation 5 (13) 1 (10)
Ganciclovir 1 (3) 1 (10)
Unknown 13 (33) 4 (40)
Outcomes
Survived 25 (63) 4 (40)
Died 5 (13) 2 (20)
Unknown 10 (25) 4 (40)

GCH: Giant cell hepatitis.